Sintx Technologies Inc 2026年季度报告

FORM 10-Q (Mark One) For the quarterly period ended March 31, 2026 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-33624 SINTX Technologies, Inc.(Exact name of registrant as specified in its charter) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports);and (2) has been subject to such filing requirements for the past 90 days: Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit and post such files); Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reportingcompany,” and “emerging growth company” in Rule 12b-2 of the Exchange Act: Non-accelerated filer If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes☐No☒ Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 4,319,279 shares of common stock, $0.01 par value, were outstanding at May 8, 2026. SINTX Technologies, Inc.Table of Contents Part I. Financial InformationItem 1. Financial StatementsCondensed Consolidated Balance Sheets (unaudited)3Condensed Consolidated Statements of Operations (unaudited)4Condensed Consolidated Statements of Stockholders’ Equity (unaudited)5Condensed Consolidated Statements of Cash Flows (unaudited)6Notes to Condensed Consolidated Financial Statements (unaudited)7Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations16Item 3. Quantitative and Qualitative Disclosures About Market Risk22Item 4. Controls and Procedures22Part II. Other InformationItem 1. Legal Proceedings23Item 1A. Risk Factors23Item 2. Unregistered Sales of Equity Securities and Use of Proceeds23Item 3. Defaults Upon Senior Securities23Item 4. Mine Safety Disclosures23Item 5. Other Information23Item 6. Exhibits24Signatures252 SINTX Technologies, Inc.Condensed Consolidated Balance Sheets - Unaudited(in thousands, except share and per share data) Cash and cash equivalents$1,889$4,140Account and other receivables, net of allowance for credit losses of $11.0 and $2.4respectively364178Prepaid expenses and other current assets677507Inventories1,394825Total current assets4,3245,650 Liabilities and Stockholders’ EquityCurrent liabilities: The condensed consolidated balance sheet as of December 31, 2025, has been prepared using information from the auditedconsolidated balance sheet as of that date. The accompanying notes are an integral part of these condensed consolidated financial statements. SINTX Technologies, Inc.Condensed Consolidated Statements of Operations - Unaudited(in thousands, except share and per share data) SINTX Technologies, Inc.Condensed Consolidated Statements of Stockholders’ Equity - Unaudited(in thousands, except share and per share data) SINTX Technologies, Inc.Condensed Consolidated Statements of Cash Flows - Unaudited(in thousands) SINTX TECHNOLOGIES, INC.NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Unaudited) 1. Organization and Summary of Significant Accounting Policies The condensed consolidated financial statements include the accounts of SINTX Technologies, Inc. (“SINTX”, or the “Company”) andits wholly-owned subsidiaries, SINTX Armor, Inc. (“SINTX Armor”), SINTX Agribiotech, Inc., Sinaptic Surgical, LLC, andTechnology Assessment and Transfer, Inc. (TA&T) through February 19, 2025 (see Note 2), which are collectively referred to as “we”orthe“Company.”SINTX Technologies is an advanced ceramics company formed in December 1996 that develops andcommercializes materials, components, and technologies for medical, industrial and agribiotech applications. SINTX develops siliconnitride (Si₃N₄)-based biomedical solutions for musculoskeletal and antipathogenic medical device applications. The Company alsomanufactures advanced silicon nitride components for leading industrial customers operating in high-performance and mission-criticalapplications. SINTX is a global leader in the research, development, and